April, 2023

article thumbnail

Advice For New Pharmacists: Lessons Form The Front Lines

IDStewardship

In this article advice for new pharmacists is provided by a pharmacist with 15 years of experience and answers are sourced from commentary on Twitter as well. Composed By: Timothy P. Gauthier, Pharm.D., BCPS, BCIDP Article Posted 1 May 2023 Recently while attending the American Pharmacist Association’s annual meeting in Phoenix, AZ I walked by a grown man at a breakfast bar wearing a head-to-toe onesie patterned with Dunkin’ Doughnuts (DD) logos.

article thumbnail

In heavyweight obesity fight, Eli Lilly launches Mounjaro head-to-head trial against Novo Nordisk's Wegovy

Fierce Pharma

In heavyweight obesity fight, Eli Lilly launches Mounjaro head-to-head trial against Novo Nordisk's Wegovy aliu Fri, 04/21/2023 - 22:35

145
145
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Tired of ‘dead end’ approach, herpes patients mobilize to demand government action

STAT

A medical student spoke emotionally about grappling with a diagnosis his classes told him little about. A young queer man took one test, got a different result on the next, and is now saving up the money needed for the most advanced diagnostics, which insurers rarely cover. A young woman tested positive, got little guidance from her doctor and found information on government sites that she interpreted as pushing abstinence.

Insurance 145
article thumbnail

FDA should remain the authority on the safety and effectiveness of medicines

PhRMA

Recent district court rulings set an alarming precedent that calls into question the authority of the U.S. Food and Drug Administration (FDA) to determine the safety and effectiveness of new medicines.

FDA 249
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

FDA Approves Qalsody, First-of-its-Kind Treatment for Rare Form of ALS

Drug Topics

The drug treats amyotrophic lateral sclerosis (ALS) associated with a mutation in the superoxide dismutase 1 (SOD1) gene (SOD1-ALS).

FDA 187
article thumbnail

Study: Pandemic Shows Link to Increased Exposure of Opioids to Postpartum Women

Pharmacy Times

Analysis indicates that there was a larger increase of filled prescriptions for individuals who delivered by cesarean birth.

181
181

More Trending

article thumbnail

Goodbye, original COVID-19 vaccines: FDA updates shot guidance, pulls monovalent authorizations

Fierce Pharma

Goodbye, original COVID-19 vaccines: FDA updates shot guidance, pulls monovalent authorizations zbecker Wed, 04/19/2023 - 11:04

Vaccines 145
article thumbnail

In counties with more Black doctors, Black people live longer, ‘astonishing’ study finds

STAT

Black people in counties with more Black primary care physicians live longer, according to a new national analysis that provides the strongest evidence yet that increasing the diversity of the medical workforce may be key to ending deeply entrenched racial health disparities. The study , published Friday in JAMA Network Open, is the first to link a higher prevalence of Black doctors to longer life expectancy and lower mortality in Black populations.

145
145
article thumbnail

MedPAC proposal threatens access to medicines in Part B

PhRMA

Next week, the Medicare Payment Advisory Commission (MedPAC) will vote on a number of policy proposals for changing Medicare Part B. One of the proposals would recommend that Congress adjust the payment for Part B medicines with accelerated approval , including medicines for serious and life-threatening diseases like cancers, rare diseases and HIV. This could compromise patient access to medicines, which is the opposite of what accelerated approval is designed to do.

238
238
article thumbnail

FDA Now Requiring New Warnings For Prescription Opioids

Drug Topics

The FDA is hoping these warnings are a positive step in what will be an extremely long process of ending opioid related deaths.

FDA 187
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Study Shows Psilocybin Therapy Improves Major Depressive Disorder in Patients With Cancer

Pharmacy Times

Based on the study results, investigators concluded that there is justification for a randomized clinical trial.

178
178
article thumbnail

5 Reasons People Fail The NAPLEX, Revisited

IDStewardship

In 2016 a pharmacy professor developed a blog post about five reasons why people fail the NAPLEX. Now years later, he revisits the topic here. Authored By: Christopher Bland, Pharm.D., BCPS, FIDSA Article Posted 17 April 2023 The NAPLEX is an examination pharmacists take to become licensed. While many pharmacy schools have high passing rates, people inevitably fail this test each year.

article thumbnail

Google, Microsoft and startups test out generative AI in healthcare

Fierce Healthcare

Google, Microsoft and startups test out generative AI in healthcare hlandi Fri, 04/14/2023 - 08:04

144
144
article thumbnail

Q&A: Chronicling the failures of the U.S. response to Covid

STAT

A new book on the U.S. response to the Covid-19 pandemic paints a picture of a country ill-prepared to cope with a dangerous biological foe, riven by partisan politics, and led by people who saw little political gain in taking ownership of managing the crisis. It also describes a country that remains ill-equipped to battle the next pandemic or major disease threat, though it lays out changes that could strengthen the country’s position.

145
145
article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

World IP Day 2023: Celebrating women leaders in innovation

PhRMA

Today PhRMA joins with innovators around the globe to recognize World IP Day and celebrate biopharmaceutical innovators who dedicate their lives to bringing new treatments and cures to patients. It’s also a day to reflect on the role Intellectual Property (IP) protections, such as patents, play in supporting the development of cutting-edge technologies.

235
235
article thumbnail

PBMs Are in the Hotseat in Washington DC

Drug Topics

The Senate Finance Committee recently released a framework for legislation, and the leaders of the “big three” PBMs are scheduled to be witnesses at another committee's hearing regarding insulin prices on May 10.

187
187
article thumbnail

Pharmacists Can Promote Vaccine Confidence in Patients

Pharmacy Times

Building strong, trusting relationships helps combat hesitancy, creating healthier communities.

Vaccines 153
article thumbnail

After Johnson & Johnson loses again in bankruptcy case, it's game on for talc lawsuits

Fierce Pharma

After Johnson & Johnson loses again in bankruptcy case, it's game on for talc lawsuits kdunleavy Mon, 04/03/2023 - 06:44

140
140
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

Layoffs are ramping up among hospitals and health systems. Here are 34 examples from 2023

Fierce Healthcare

Layoffs are ramping up among hospitals and health systems.

Hospitals 143
article thumbnail

Demand for home health aides is soaring. So why are they still so undervalued?

STAT

On most days around 2pm, home health aide Duane Crichlow can be found in an apartment in Sunset Park, Brooklyn, playing catch with his client — a man in his 30s with a developmental disability who is quick to give Crichlow hugs and kisses. If it’s nice outside, Crichlow will walk his client, who is nonverbal and in a wheelchair half the time, down three flights of stairs, hauling the wheelchair back and forth separately.

145
145
article thumbnail

Three facts about health care spending

PhRMA

There is increasing talk about making changes to our health care system to lower costs for patients and address misaligned incentives. These are important conversations that could lead to meaningful improvements, but only if policymakers take a holistic approach to address all the health care drivers. Far too often, there is a singular focus on prescription medicines, ignoring the other parts of the supply chain that are key drivers of U.S. health care spending.

Insurance 235
article thumbnail

FDA Clears Wearable Insulin Delivery Device Omnipod GO for Type-2 Diabetes

Drug Topics

Insulet plans to commercialize the new product in the United States starting in 2024.

FDA 187
article thumbnail

Nutrition Can Speed Up Healing After a Traumatic Brain Injury

Pharmacy Times

Clinicians are often focused on reducing brain damage after traumatic injury, but considering nutrition is an important component to healing.

149
149
article thumbnail

J&J opens its wallet with whopping $8.9B talc settlement offer

Fierce Pharma

J&J opens its wallet with whopping $8.

138
138
article thumbnail

VA pauses $16B Oracle Cerner EHR deployments indefinitely to address error-ridden early rollout

Fierce Healthcare

VA pauses $16B Oracle Cerner EHR deployments indefinitely to address error-ridden early rollout dmuoio Fri, 04/21/2023 - 11:36

Cerner 143
article thumbnail

Hospitals pledge to protect patient privacy. Almost all their websites leak visitor data like a sieve

STAT

Every hospital in America promises to protect the privacy of its patients and the details of their medical care. And almost every one of them uses sophisticated data tools to track and share the personal information of visitors as soon as they start clicking on their websites. A new study found that 99% of U.S. hospitals employed online data trackers in 2021 that transmitted visitors’ information to a broad network of outside parties, including major technology companies, data brokers, an

Hospitals 145
article thumbnail

Policies need to address the growing threat of antimicrobial resistance

PhRMA

Today, the House Energy & Commerce Subcommittee on Oversight and Investigations will be holding a hearing on the growing public health threat of antimicrobial resistance (AMR). AMR occurs when microorganisms such as bacteria, viruses, fungi and parasites develop the ability to survive against the drugs designed to kill them. Recognized by the World Health Organization (WHO) as “one of the biggest threats to global health, food security and development today,” AMR is a growing crisis that has

211
211
article thumbnail

The Prevalence Of Long COVID in Vaccinated vs. Unvaccinated Children

Drug Topics

Post-COVID-19 conditions were more common in unvaccinated children than in children who had received at least 1 dose of a COVID-19 vaccine.

Vaccines 187
article thumbnail

Limitations on Reproductive Rights Makes Agonizing Decisions Even Harder for Pregnant Women With Cancer

Pharmacy Times

Even before the Dobbs ruling overturned country-wide reproductive rights, the oncology field was already facing a dearth of maternal care access challenges.

149
149
article thumbnail

Apellis hits setback in ALS trial after pair of pegcetacoplan approvals

Fierce Pharma

Apellis hits setback in ALS trial after pair of pegcetacoplan approvals fkansteiner Mon, 04/24/2023 - 10:56

134
134
article thumbnail

New AI-driven long COVID app coming soon to individual, enterprise customers

Fierce Healthcare

New AI-driven long COVID app coming soon to individual, enterprise customers agliadkovskaya Wed, 04/26/2023 - 14:04

142
142
article thumbnail

Opinion: Why involuntary treatment for addiction is a dangerous idea

STAT

As the overdose crisis rages on and the pandemic-fatigued public runs low on empathy, there have been increasing calls for expanded involuntary commitment for people with substance use disorder. Some of the advocacy for more coercive treatment seems rooted in a disdain for people who use drugs, most especially when their drug use occurs visibly and in close geographic proximity to affluence, for example in San Francisco or in the Massachusetts Avenue and Melnea Cass area of Boston which borders

144
144
article thumbnail

What they are saying: Experts reinforce that TRIPS waiver expansion is harmful and unnecessary

PhRMA

At the direction of the U.S. Trade Representative, the U.S. International Trade Commission (USTIC) is investigating the impact of a proposed waiver of intellectual property (IP) protections for COVID-19 diagnostics and therapeutics under the World Trade Organization Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS). Public submissions to the USITC from experts across patient groups, academia, public health, labor and the private sector make clear that, much like the orig

Vaccines 208